Asante Solutions Inc (NASDAQ:PUMP) issued its quarterly earnings data on Wednesday. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.05, reports. The firm had revenue of $282.70 million during the quarter, compared to analyst estimates of $261.69 million. The firm’s revenue for the quarter was up 32.4% on a year-over-year basis.

A number of research analysts have commented on the company. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $19.00 price objective on shares of Asante Solutions in a report on Thursday, July 20th. Credit Suisse Group set a $15.00 target price on Asante Solutions and gave the stock a “buy” rating in a report on Friday, August 11th. Barclays PLC lowered Asante Solutions from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $18.00 to $12.00 in a report on Wednesday, July 12th. Piper Jaffray Companies reissued a “buy” rating and set a $14.00 target price (down from $15.50) on shares of Asante Solutions in a report on Wednesday, July 12th. Finally, R. F. Lafferty assumed coverage on Asante Solutions in a report on Wednesday, July 12th. They set a “buy” rating and a $32.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $18.73.

COPYRIGHT VIOLATION WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at

About Asante Solutions

Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.

Receive News & Ratings for Asante Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions Inc and related companies with's FREE daily email newsletter.